Strategic Partnerships Position Pulmonx to partner with health systems and pulmonology networks that emphasize minimally invasive COPD therapies, leveraging Zephyr valves as a preferred option for eligible emphysema patients to expand adoption and referral channels.

Conference Visibility Capitalize on frequent industry conference appearances (Bank of America Securities, Goldman Sachs Health Care, Citi Unplugged) to schedule targeted outreach, executive briefings, and demos with investment analysts, healthcare administrators, and key opinion leaders.

Clinical Expansion Highlight the Zephyr valve’s minimally invasive benefits to drive adoption in centers seeking COPD treatment options with reduced recovery times, targeting hospitals expanding interventional pulmonology programs.

Financial Outreach Engage with potential partners and customers around total cost of care, reimbursement pathways, and device economics to address budgeting needs as the company pursues broader market penetration and payer clarity.

Global Growth Leverage leadership’s public presence and recent leadership changes as talking points to reassure stakeholders about continuity, strategic vision, and ongoing product development in international markets and newly expanding health systems.